Pieris Pharmaceuticals, Inc.
(NASDAQ : PIRS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -6.25%68.121.0%$1411.92m
BIIBBiogen, Inc. -0.53%308.451.5%$631.31m
REGNRegeneron Pharmaceuticals, Inc. 0.86%435.332.6%$529.51m
AMGNAmgen, Inc. -2.02%199.401.3%$515.81m
ILMNIllumina, Inc. 0.51%261.253.5%$397.85m
VRTXVertex Pharmaceuticals, Inc. -0.80%221.521.9%$345.64m
MRNAModerna, Inc. -10.63%23.380.0%$337.80m
ALXNAlexion Pharmaceuticals, Inc. -0.05%92.042.0%$220.59m
CODXCo-Diagnostics, Inc. -18.55%13.000.0%$201.50m
AAgilent Technologies, Inc. -1.63%76.171.6%$167.01m
EXASEXACT Sciences Corp. 1.44%81.9824.0%$165.96m
BMRNBioMarin Pharmaceutical, Inc. 0.18%89.984.3%$114.94m
INCYIncyte Corp. -1.77%74.502.5%$108.43m
SGENSeattle Genetics, Inc. 2.21%110.706.1%$108.23m
NVAXNovavax, Inc. 20.00%14.16184.0%$78.88m

Company Profile

Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of Anticalin-based drugs. Its pipeline includes immuno-oncology, respiratory, and anemia and other disease areas. The company was founded by Claus Schalper and Arne Skerra in 2001 and is headquartered in Boston, MA.